(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ESOLIEF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ESOLIEF

ST13

US500000079356324

Class

5

Filing

79356324

Registration

7318301

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

06/06/2024

Trademark type

Combined

Nice classes

5

Filing date

09/30/2022

Registration date

03/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/05/2024

Last transaction

03/05/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

16

Owner location

IT

Examiner

STRUCK, ROBERT

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Biofarma S.r.l.

Representatives

Matthew J. Curran Maine, Cernota & Curran

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals for the treatment of gastroesophageal reflux disease; dietetic foods and beverages adapted for medical use; dietary and nutritional supplements; medicinal herbs; plant extracts for pharmaceutical purposes; nutritional supplements; dietetic beverages adapted for medical purposes; phytotherapy preparations for medical purposes; dietetic foods adapted for medical purposes; freeze-dried food adapted for medical purposes; capsules sold empty for medicines; candymedicated; cachets for medicinal purposescapsules sold empty for pharmaceuticals; ferments for pharmaceutical purposes; vitamin preparations; syrups for pharmaceutical purposes for the treatment of gastroesophageal reflux disease

Publications

History of USPTO decisions and trademark events.

22 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2024

GPNX

NOTIFICATION PROCESSED BY IB

12/19/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/19/2023

PUBO

PUBLISHED FOR OPPOSITION

12/19/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/29/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/29/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/24/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/24/2023

RFNP

REFUSAL PROCESSED BY IB

05/31/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/11/2023

RFRR

REFUSAL PROCESSED BY MPU

05/10/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/21/2023

CNRT

NON-FINAL ACTION WRITTEN

03/20/2023

DOCK

ASSIGNED TO EXAMINER

03/16/2023

MAFR

APPLICATION FILING RECEIPT MAILED

12/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/02/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/01/2022

Continuous trademark protection

Get notified about every new filing that threatens ESOLIEF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.